Related references
Note: Only part of the references are listed.Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel
Anat Eldar-Boock et al.
BIOMATERIALS (2011)
EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
Chun-Ju Chang et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
The ABCG2 resistance network of glioblastoma
Anne-Marie Bleau et al.
CELL CYCLE (2011)
Drug transporters of platinum-based anticancer agents and their clinical significance
Herman Burger et al.
DRUG RESISTANCE UPDATES (2011)
The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Susanna Leskelae et al.
ENDOCRINE-RELATED CANCER (2011)
MicroRNA-200a inhibits CD133/1+ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2
Qiuhua Wu et al.
GYNECOLOGIC ONCOLOGY (2011)
Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
Enfeng Wang et al.
PLOS ONE (2011)
Specific Unsaturated Fatty Acids Enforce the Transdifferentiation of Human Cancer Cells toward Adipocyte-like Cells
Antonio Ruiz-Vela et al.
STEM CELL REVIEWS AND REPORTS (2011)
Clinical significance of side population in ovarian cancer cells
Shinji Hosonuma et al.
HUMAN CELL (2011)
Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
Ramandeep Rattan et al.
NEOPLASIA (2011)
Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
Karina Dahl Steffensen et al.
JOURNAL OF ONCOLOGY (2011)
EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells
Olafur Andri Stefansson et al.
BREAST CANCER RESEARCH (2011)
Dynamic emergence of the mesenchymal CD44posCD24neg/low phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin)
Cristina Oliveras-Ferraros et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate
Xiaoyan Jiang et al.
BLOOD (2010)
Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma
Guo-Fen Yang et al.
BMC CANCER (2010)
Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
L. Hu et al.
BRITISH JOURNAL OF CANCER (2010)
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
David G. DeNardo et al.
CANCER AND METASTASIS REVIEWS (2010)
The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells
Hiroaki Kajiyama et al.
CANCER SCIENCE (2010)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
Roberta Pang et al.
CELL STEM CELL (2010)
Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions
Sivan Elloul et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
CD44, a therapeutic target for metastasising tumours
Veronique Orian-Rousseau
EUROPEAN JOURNAL OF CANCER (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Unmasking the complexities of mucinous ovarian carcinoma
Michael Frumovitz et al.
GYNECOLOGIC ONCOLOGY (2010)
EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma
Benoit Terris et al.
JOURNAL OF HEPATOLOGY (2010)
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome
Ting Li et al.
LABORATORY INVESTIGATION (2010)
Overexpression of CD133 Promotes Drug Resistance in C6 Glioma Cells
James M. Angelastro et al.
MOLECULAR CANCER RESEARCH (2010)
ABCG2: A potential marker of stem cells and novel target in stern cell and cancer therapy
Xi-wei Ding et al.
LIFE SCIENCES (2010)
Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours
Vitaly Sviatoha et al.
MELANOMA RESEARCH (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immunohistochemical features of CD133 expression: Association with resistance to chemoradiotherapy in rectal cancer
Susumu Saigusa et al.
ONCOLOGY REPORTS (2010)
Human Endometrial Side Population Cells Exhibit Genotypic, Phenotypic and Functional Features of Somatic Stem Cells
Irene Cervello et al.
PLOS ONE (2010)
Pharmacogenomics of paclitaxel
Cristina Rodriguez-Antona
PHARMACOGENOMICS (2010)
Small-molecule delivery by nanoparticles for anticancer therapy
Zhuo (Georgia) Chen
TRENDS IN MOLECULAR MEDICINE (2010)
Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux
Sagar Agarwal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
ABC transporters in cancer: more than just drug efflux pumps
Jamie I. Fletcher et al.
NATURE REVIEWS CANCER (2010)
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer
Yu-Chih Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Identification and targeting of cancer stem cells
Tobias Schatton et al.
BIOESSAYS (2009)
Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties
C. Hegedus et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
David Horst et al.
CANCER INVESTIGATION (2009)
Aldehyde Dehydrogenase-Expressing Colon Stem Cells Contribute to Tumorigenesis in the Transition from Colitis to Cancer
Joseph E. Carpentino et al.
CANCER RESEARCH (2009)
MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
Resham Bhattacharya et al.
CANCER RESEARCH (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression
Koji Morimoto et al.
CANCER SCIENCE (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance
Ayesha B. Alvero et al.
CELL CYCLE (2009)
CD24 Is a Novel Predictor for Poor Prognosis of Hepatocellular Carcinoma after Surgery
Xin-Rong Yang et al.
CLINICAL CANCER RESEARCH (2009)
Cancer induction by restriction of oncogene expression to the stem cell compartment
Maria Perez-Caro et al.
EMBO JOURNAL (2009)
Pharmacogenomics of platinum-based chemotherapy in NSCLC
Michelle A. T. Hildebrandt et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
Taro Yamashita et al.
GASTROENTEROLOGY (2009)
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
Xiaoxia Hu et al.
GYNECOLOGIC ONCOLOGY (2009)
Ovarian carcinoma pathology and genetics: recent advances
C. Blake Gilks et al.
HUMAN PATHOLOGY (2009)
CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells
Sung Pil Hong et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Overexpression of Epithelial Cell Adhesion Molecule in Primary, Metastatic, and Recurrent/Chemotherapy-Resistant Epithelial Ovarian Cancer Implications for Epithelial Cell Adhesion Molecule-Specific Immunotherapy
Stefania Bellone et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma
Alexei V. Salnikov et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Adjuvant Therapy With the Monoclonal Antibody Edrecolomab Plus Fluorouracil-Based Therapy Does Not Improve Overall Survival of Patients With Stage III Colon Cancer
Anthony L. A. Fields et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Antibodies targeting cancer stem cells A new paradigm in immunotherapy?
Mahendra P. Deonarain et al.
MABS (2009)
Epigenetic regulation of CD133 and tumorigenicity of CD133+ovarian cancer cells
T. Baba et al.
ONCOGENE (2009)
Overexpression of CD24, c-myc and Phospholipase 2A in Prostate Cancer Tissue Samples Obtained by Needle Biopsy
Balint Nagy et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression
Pedro C. Lara et al.
RADIATION ONCOLOGY (2009)
Management of Women With Newly Diagnosed Ovarian Cancer
Carolyn Krasner et al.
SEMINARS IN ONCOLOGY (2009)
Surgical Management of Recurrent Ovarian Cancer
Mario M. Leitao et al.
SEMINARS IN ONCOLOGY (2009)
Building a Framework for Embryonic Microenvironments and Cancer Stem Cells
Antonio Ruiz-Vela et al.
STEM CELL REVIEWS AND REPORTS (2009)
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
Shigeo Takaishi et al.
STEM CELLS (2009)
Ovarian Cancer: A Clinical Challenge That Needs Some Basic Answers
Kate Lawrenson et al.
PLOS MEDICINE (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
L. M. Smith et al.
BRITISH JOURNAL OF CANCER (2008)
Endometrioid epithelial ovarian cancer - 20 years of prospectively collected data from a single center
Dawn J. Storey et al.
CANCER (2008)
Significance of CD90+ cancer stem cells in human liver cancer
Zhen Fan Yang et al.
CANCER CELL (2008)
Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer
Sang Joon Shin et al.
CANCER LETTERS (2008)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors
Shu Zhang et al.
CANCER RESEARCH (2008)
Cancer stem cells and chemoradiation resistance
Hideshi Ishii et al.
CANCER SCIENCE (2008)
Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
Ralph J. DeBerardinis
GENETICS IN MEDICINE (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
Expression of CD133-1 and CD133-2 in ovarian cancer
G. Ferrandina et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The Stem Cell-Associated Antigen CD133 (Prominin-1) Is a Molecular Therapeutic Target for Metastatic Melanoma
Germana Rappa et al.
STEM CELLS (2008)
Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance
Hyun Ju Lee et al.
UROLOGY (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Cancer stem cell and cancer stemloids
Mikhail V. Blagosklonny
CANCER BIOLOGY & THERAPY (2007)
Right on target: eradicating leukemic stem cells
Daniela S. Krause et al.
TRENDS IN MOLECULAR MEDICINE (2007)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers
Bing Xin et al.
CANCER (2007)
Phenotypic characterization of human colorectal cancer stem cells
Piero Dalerba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Functionalized micellar systems for cancer targeted drug delivery
Damon Sutton et al.
PHARMACEUTICAL RESEARCH (2007)
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Shengyong Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma
Craig D. Peacock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Peroxisome proliferator-activated receptor-γ agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines
Y. -C. Yang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Identification of pancreatic cancer stem cells
Chenwei Li et al.
CANCER RESEARCH (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
The response of CD24-/low/CD44+ breast cancer-initiating cells to radiation
Tiffany M. Phillips et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
ABCC2 (MRP2, cMOAT) can be localized in the nuclear membrane of ovarian carcinomas and correlates with resistance to cisplatin and clinical outcome
Pawel Surowiak et al.
CLINICAL CANCER RESEARCH (2006)
Cellular and molecular consequences of peroxisome proliferator-activated receptor-γ activation in ovarian cancer cells
Sara Vignati et al.
NEOPLASIA (2006)
Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness
Paul P. Szotek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Proliferating cell nuclear antigen, survivin, and CD34 expressions in pancreatic cancer and their correlation with hypoxia-inducible factor 1α
Haiyan Wei et al.
PANCREAS (2006)
PPARγ and human metabolic disease
RK Semple et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Cancer stem cells: An old idea - A paradigm shift
MS Wicha et al.
CANCER RESEARCH (2006)
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia
A. M. Martelli et al.
LEUKEMIA (2006)
Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk
AE van Herwaarden et al.
CARCINOGENESIS (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules
AV Boddy et al.
CLINICAL CANCER RESEARCH (2005)
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1)
AE Greijer et al.
JOURNAL OF PATHOLOGY (2005)
The effects of histone deacetylase inhibitors on heterochromatin: implications for anticancer therapy?
A Taddei et al.
EMBO REPORTS (2005)
Will cancer stem cells provide new therapeutic targets?
F Behbod et al.
CARCINOGENESIS (2005)
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma
R Galli et al.
CANCER RESEARCH (2004)
Self-renewal and solid tumor stem cells
M Al-Hajj et al.
ONCOGENE (2004)
Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis
JH Wu et al.
CANCER RESEARCH (2004)
Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells
DE Banker et al.
BLOOD (2004)
Stem cell origin of cancer and differentiation therapy
S Sell
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
CD44v6: a target for antibody-based cancer therapy
KH Heider et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists
C Grommes et al.
LANCET ONCOLOGY (2004)
Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
P Sabbatini et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Cytotoxic activity of novel human monoclonal antibody MT201 against primary ovarian tumor cells
W Xiang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
THY1 expression is associated with tumor suppression of human ovarian cancer
HR Abeysinghe et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression
DL Stirewalt et al.
LEUKEMIA RESEARCH (2003)
Functional and molecular characterisation of mammary side population cells (vol 5, pg R1, 2003)
AJ Alvi et al.
BREAST CANCER RESEARCH (2003)
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival
G Kristiansen et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Neoadjuvant chemotherapy for the management of ovarian cancer
PE Schwartz
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2002)
Multidrug resistance gene-1 is a useful predictor of paclitaxel-based chemotherapy for patients with ovarian cancer
S Kamazawa et al.
GYNECOLOGIC ONCOLOGY (2002)
Expression of CD44S and CD44v5 is more common in stage III than in stage I serous ovarian carcinomas
AM Afify et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2001)
Cellular stress response and apoptosis in cancer therapy
I Herr et al.
BLOOD (2001)
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
S Zhou et al.
NATURE MEDICINE (2001)
Ovarian surface epithelium: Biology, endocrinology, and pathology
N Auersperg et al.
ENDOCRINE REVIEWS (2001)
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
J Taipale et al.
NATURE (2000)
Share Paper
